ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $128,000 | -28.1% | 26,000 | -22.8% | 0.00% | – |
Q2 2021 | $178,000 | -41.8% | 33,700 | -47.1% | 0.00% | – |
Q1 2021 | $306,000 | +10.9% | 63,700 | 0.0% | 0.00% | – |
Q4 2020 | $276,000 | +5.3% | 63,700 | 0.0% | 0.00% | – |
Q3 2020 | $262,000 | +21.3% | 63,700 | -24.4% | 0.00% | – |
Q2 2020 | $216,000 | -12.9% | 84,300 | -1.7% | 0.00% | – |
Q1 2020 | $248,000 | -5.0% | 85,739 | +24.4% | 0.00% | – |
Q4 2019 | $261,000 | -13.3% | 68,939 | +17.0% | 0.00% | – |
Q3 2019 | $301,000 | -17.5% | 58,928 | +0.2% | 0.00% | – |
Q2 2019 | $365,000 | +305.6% | 58,797 | +366.8% | 0.00% | – |
Q1 2019 | $90,000 | -15.9% | 12,597 | +0.8% | 0.00% | – |
Q4 2018 | $107,000 | -68.0% | 12,497 | -25.0% | 0.00% | – |
Q3 2018 | $334,000 | -21.8% | 16,661 | +0.8% | 0.00% | – |
Q2 2018 | $427,000 | – | 16,532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |